The activity included a series of technical talks and key recommendations to optimize therapies and maximize the effectiveness of treatments used against Caligidosis, one of the main health challenges faced by the Chilean salmon farming industry.
With a high participation of professionals from the technical and field fields of salmon producing companies and suppliers, the Seminar was held on 19 May.Tools to ensure good practices and effectiveness in antiparasitic treatments", which took place at the Courtyard by Marriott Hotel in Puerto Montt (Los Lagos region).
The meeting was organized by Sealice Partners, Chilean company that was born at the end of 2025 as a new alternative to provide technical, scientific and strategic advice to its clients through specialized services and R&D for the evaluation and monitoring of solutions against Caligidosis. It also had the sponsored by Aqua Pharma, Virbac, SalmoClinic, Imenco Aqua y AcuaNativa, and with the sponsorship of ADL Diagnostic Chile, TEKBios, the Club Innovación Acuícola de Chile, the Faculty of Veterinary and Pecuaria Sciences of the University of Chile and the Institute of Aquaculture and Environment of the Universidad Austral de Chile.
The aim of the seminar was to promote the use of good practices in treatments applied for the control of Caligus rogercresseyiin addition to promoting a discussion that allows to unify criteria in the approach to the disease, in order to minimize operational failures, health risks and productive losses. At the same time, the need to maintain high technical rigour at the time of the application of the therapies was reinforced, as was the need for strict criteria and methods of control during the implementation and subsequent evaluation.
Among the topics addressed during the activity, they highlighted: good practices, protocols, methodologies and critical and safety variables in antiparasitic treatments; optimization of treatments in continuous flow; oxygenation in therapies via bathroom; key points in treatments with hydrogen peroxide; good practices in oral treatments; technical management of natural additives and interaction between branchial pathologies and antiparasitic treatments.
The CEO of Sealice Partners, María Isabel Pizarro“We are left with a very positive balance. We were able to bring together experts with a lot of experience in technical assistance, with field staff very interested in obtaining quality information to improve therapies in their daily application. There was a very favourable dynamic that we believe was much needed in the industry. We were also able to verify this with the high level of call we reached, adding almost 150 participants.”
The executive thanked “all the companies and organizations that participated in this instance: both the exhibitors, as well as our sponsors and sponsors; also, of course, the attendees who gave special vitality and meaning to this meeting. This synergy shows that there is a lot of interest in dealing with the Caligidosis together. We hope that this collaboration will be maintained and effectively led to better results. results”.
Similar opinion had the Head of Sealice Partners Laboratory, Veronica Osorio, who said that “we closed an enriching day and very well evaluated by the participants themselves and that, for all of us, is fundamental. In the industry there is much talk about the biology of Caligus and other relevant aspects of the disease, but it was very good to offer this space to bring useful information to those who deal, day by day, with the parasite. We are convinced that this connection and integral look will be to move towards a more sustainable industry.”
By the same token, the partner and co-founder of Sealice Partners, Patricio Bustos“This seminar, because of the quality of the exhibitions and the conversations that took place, was a learning experience for all. I congratulate and thank all those who made it possible and, most especially, Maria Isabel and Veronica, who, in addition to promoting the company’s take-off and development – with their services and specialized studies in Caligus – organized this remarkable event in a very short time.”
The executive added that, for ADL Diagnostic Chile, the incorporation of Sealice Partners as a subsidiary represents a relevant milestone, as it concretes a process of deep specialization in the control of Caligus through a team of professionals of long history and the highest level. “This one experience technology is empowered and complemented directly with the market vision, strategic direction and support of the joint work with ADL, consolidating an integral synergy for the industry,” he concluded.
